Fagerlund K A
Minneapolis VA School of Anesthesia, Minnesota, USA.
AANA J. 1998 Apr;66(2):153-60.
Increased public attention to the costs of healthcare in the United States has resulted in greater scrutiny of all aspects of the health industry, including the education of healthcare providers. Because Certified Registered Nurse Anesthetists will, as in the past, have a major role in healthcare delivery systems of the future, knowledge of the educational costs and resulting benefits of this advanced practice nurse is important. This is the first comprehensive study of the economic investment in nurse anesthesia education. This study sought to determine the costs, benefits, and net benefits of nurse anesthesia education to four entities: (1) students, (2) clinical institutions, (3) academic institutions, and (4) others, primarily taxpayers. Considering these four entities together, the costs, benefits, and net benefits to society as a whole can be estimated. A prototypical nurse anesthesia educational program was developed, using the most common characteristics found among such programs in the United States. Data were then collected to estimate the costs and benefits to the four entities as they function within this prototypical program. The study concluded that all entities realize a net benefit from the investment by sponsorship or association with nurse anesthesia education, except the academic institution, which is a nonprofit institution and does not show a gain. Nurse anesthesia students show the highest internal rate of return on their investment, followed by others (primarily other taxpayers), and the clinical institution.
美国公众对医疗保健成本的关注度不断提高,这导致对医疗行业各个方面的审查更加严格,包括医疗保健提供者的教育。由于注册护士麻醉师在未来的医疗保健提供系统中仍将像过去一样发挥重要作用,了解这种高级实践护士的教育成本及其带来的益处非常重要。这是对护士麻醉教育经济投资的首次全面研究。本研究旨在确定护士麻醉教育对四个实体的成本、效益和净效益:(1)学生,(2)临床机构,(3)学术机构,以及(4)其他方,主要是纳税人。综合考虑这四个实体,可以估算出对整个社会的成本、效益和净效益。利用在美国此类项目中发现的最常见特征,制定了一个典型的护士麻醉教育项目。然后收集数据,以估算这四个实体在这个典型项目中运作时的成本和效益。研究得出结论,除了作为非营利机构且未显示出收益的学术机构外,所有实体通过赞助或参与护士麻醉教育投资都实现了净效益。护士麻醉专业的学生在其投资上显示出最高的内部收益率,其次是其他方(主要是其他纳税人)和临床机构。